What Is IVF Treatment? Process, Cost & Success Rate in India

What Is IVF Treatment and How Does It Work?

IVF — In Vitro Fertilisation — is a medical procedure in which eggs are retrieved from a woman's ovaries, fertilised with sperm outside the body in a controlled laboratory environment, and the resulting embryo is transferred into the uterus to achieve pregnancy.

The phrase “in vitro” is Latin for “in glass,” a reference to the laboratory dish where fertilisation occurs. Everything that would normally happen inside the fallopian tube — egg and sperm meeting, fertilisation, early cell division — instead happens in a precisely controlled lab environment under the supervision of an embryologist.

IVF is classified as an Assisted Reproductive Technology (ART). In India, all ART procedures are regulated under the ART (Regulation) Act, 2021, administered by the National Registry of Medical Institutions and the State ART Boards. Any clinic offering IVF must hold a valid registration under this Act.

The reason IVF works where natural conception and simpler treatments fail is structural: it removes the body's anatomical barriers from the equation entirely. Blocked fallopian tubes, low sperm count, poor egg quality, and hostile cervical mucus all become irrelevant when fertilisation happens in a laboratory dish and the embryo is placed directly into the uterus via a thin catheter.

What Does an IVF Cycle Actually Involve?

A single IVF cycle is not one procedure — it is a sequence of six coordinated clinical stages that span four to six weeks of active treatment. Each stage builds on the last, and the outcome of each affects the next. Here is the structure at a glance before the detailed breakdown later in this guide:

The total active cycle — from first injection to pregnancy blood test — is four to six weeks. Including the initial consultation and pre-cycle diagnostic workup, the complete journey from first appointment to test result is typically eight to twelve weeks.

How Is IVF Different from Natural Conception?

In natural conception, ovulation produces one egg per cycle, which travels down the fallopian tube where it may be fertilised by sperm. If fertilised, it travels to the uterus over five to six days and implants in the endometrium.

IVF replicates this process outside the body and modifies it in two critical ways. First, stimulation drugs cause both ovaries to mature multiple eggs simultaneously — typically eight to fifteen — instead of the one produced in a natural cycle. This is called controlled ovarian hyperstimulation, and it is what makes IVF more efficient than natural conception: more eggs retrieved means more embryos cultured, which means a higher probability of at least one chromosomally normal blastocyst available for transfer.

Second, the embryo does not travel through the fallopian tube at all. After five days in the lab, the embryo is loaded into a fine flexible catheter and guided directly into the uterine cavity under ultrasound. The tube is bypassed entirely, which is why IVF works for women with blocked or absent fallopian tubes.

When Was IVF First Used and What Is Its History in India?

The world's first IVF baby, Louise Brown, was born on 25 July 1978 in Oldham, England, conceived through the research of physiologist Robert Edwards and gynaecologist Patrick Steptoe. Robert Edwards was awarded the Nobel Prize in Physiology or Medicine in 2010 for this work.

India's officially recognised first IVF baby — named Harsha — was born on 6 August 1986 at KEM Hospital in Mumbai under the supervision of Dr. T.C. Anand Kumar, eight years after Louise Brown. In 1978, Dr. Subhash Mukhopadhyay in Kolkata claimed to have independently produced an IVF birth just 67 days after Louise Brown — a claim that was later substantiated but was not officially recognised during his lifetime due to institutional and political obstacles.

Today, India is one of the world's largest IVF markets by volume. The ICMR's National Registry of ART Clinics and Banks lists over 2,500 registered facilities across the country as of 2025. India's cost advantage — IVF here costs 60 to 70 percent less than in the UK or United States — has also made it a significant destination for cross-border fertility treatment, particularly from the Middle East, Southeast Asia, and the Indian diaspora abroad.

What Is the Difference Between IVF, ICSI, and IUI?

These three abbreviations appear throughout fertility treatment conversations, often used interchangeably or without explanation. They are not interchangeable. IVF, ICSI, and IUI are three distinct procedures — different in complexity, cost, invasiveness, and the clinical situations where each is appropriate.

Understanding the difference matters because your diagnosis determines which path is clinically indicated. Choosing IUI when your situation requires IVF wastes time. Jumping to IVF when IUI has not been attempted first may mean unnecessary expense and physical burden. The sections below explain each procedure and then lay out a decision framework your specialist will use — and that you should understand before your first appointment.

What Is IUI and How Does It Differ from IVF?

IUI — Intrauterine Insemination — is the simplest form of assisted reproduction. A prepared sperm sample (washed and concentrated in a lab) is loaded into a thin catheter and placed directly inside the uterine cavity at the time of ovulation. Fertilisation still happens inside the body, inside the fallopian tube, exactly as in natural conception. The only difference is that the sperm bypasses the cervix and arrives in the uterus at higher concentration.

IUI does not involve egg retrieval, laboratory fertilisation, or embryo culture. There are no injections beyond optional mild ovarian stimulation (usually oral tablets like letrozole or clomiphene, or low-dose injectable gonadotropins). The procedure itself takes five to ten minutes and requires no anaesthesia.

The trade-off for that simplicity is success rate. IUI achieves clinical pregnancy in approximately 10 to 20 percent of cycles for appropriate candidates — roughly half the per-cycle success rate of IVF. The lower rate is expected: IUI still depends on the sperm and egg meeting inside the fallopian tube without laboratory assistance. Any structural barrier, poor sperm motility, or significant egg quality issue reduces IUI's effectiveness rapidly.

What Is ICSI and Is It Different from IVF?

ICSI — Intracytoplasmic Sperm Injection — is not a separate treatment from IVF. It is a fertilisation technique used within an IVF cycle, replacing the standard fertilisation step. In standard IVF, retrieved eggs and prepared sperm are placed together in a culture dish, and the sperm fertilises the egg naturally over several hours. In ICSI, an embryologist selects a single sperm under high-powered microscope magnification and injects it directly into the cytoplasm of each mature egg using a glass microneedle. Every other stage — ovarian stimulation, egg retrieval, embryo culture, embryo transfer — is identical to a standard IVF cycle.

ICSI was developed in 1992 at the Vrije Universiteit Brussel by Dr. Gianpiero Palermo and colleagues to address severe male factor infertility cases where sperm could not fertilise eggs independently. It has since become the most commonly used fertilisation method in India, used in the majority of IVF cycles whether or not a male factor is present.

The reason ICSI has become the default in many Indian clinics goes beyond male factor indications: it gives the embryologist direct control over which sperm fertilises each egg, and it eliminates the risk of complete fertilisation failure — a rare but devastating outcome in standard IVF where no eggs fertilise after mixing with sperm. For this reason, ICSI is now widely used even in cycles where sperm parameters are normal.

IVF vs ICSI vs IUI — Full Comparison Table

When Is IUI Recommended Before IVF?

IUI is a clinically appropriate first-line treatment when all of the following conditions are met:

• Fallopian tubes are open and functional — confirmed by HSG (hysterosalpingography) or SSG (sonosalpingography). IUI is not appropriate if one or both tubes are blocked, because the sperm has no pathway to the egg.
• Sperm parameters are mildly abnormal or normal — IUI requires a post-wash total motile sperm count (TMSC) of at least 5–10 million. Below this threshold, fertilisation probability with IUI drops significantly.
• Ovulation is present or can be induced — IUI works best when the woman ovulates, either naturally or with mild stimulation (letrozole, clomiphene, or low-dose gonadotropins).
• Age is under 37 and ovarian reserve is adequate — at older ages or with diminished ovarian reserve (low AMH, high FSH), IUI success rates drop sharply and proceeding directly to IVF is the more time-efficient option.

Most fertility specialists recommend attempting two to four IUI cycles before moving to IVF, assuming no contraindications exist. After three to four failed IUI cycles in an appropriate candidate, the evidence supports transitioning to IVF rather than continuing with further IUI attempts.

When Should You Skip IUI and Proceed Directly to IVF?

Certain clinical situations make IUI unlikely to succeed. In these cases, proceeding directly to IVF is the evidence-based recommendation — not a default to a more expensive option, but a recognition that the structural barriers to natural fertilisation cannot be overcome by IUI.

• Both fallopian tubes are blocked or absent — IUI requires at least one functional tube. With bilateral tubal occlusion, IUI cannot work.
• Severe male factor infertility — post-wash TMSC below 1–5 million, or surgically retrieved sperm (TESA, MESA, PESA) from men with azoospermia. ICSI within an IVF cycle is the only viable path.
• Endometriosis Stage III or IV — severe endometriosis distorts pelvic anatomy, impairs egg quality, and creates a hostile uterine environment that reduces IUI success dramatically.
• Advanced maternal age (38 and above) — time is the critical resource. Each failed IUI cycle at 38+ costs one month of declining egg quality. Proceeding to IVF from the outset maximises per-cycle success probability and cumulative success over fewer treatment cycles.
• Diminished ovarian reserve — low AMH (below 1.0 ng/mL) or low antral follicle count (below 5–7 follicles). IUI with poor ovarian reserve has minimal clinical benefit; IVF maximises the use of the eggs available.
• Previous failed IVF or recurrent pregnancy loss with chromosomal cause — PGT-A (Preimplantation Genetic Testing for Aneuploidies) requires an IVF cycle to test embryos before transfer. This is not possible with IUI.

Who Is IVF Recommended For — and Who Should Try Simpler Options First?

IVF is not the first-line treatment for most couples experiencing infertility. It is a powerful tool for specific clinical situations where natural conception or less invasive treatments face structural or biological barriers that cannot be overcome any other way. Recommending IVF when a couple's situation calls for IUI or timed intercourse is not aggressive treatment — it is premature treatment, and it comes at a real cost in money, time, and physical burden.

This section describes the clinical indications where IVF is appropriate, the diagnostic thresholds that guide those decisions, and — equally important — the situations where starting with IVF is unnecessary.

What Diagnostic Tests Come Before an IVF Recommendation?

Before any fertility specialist recommends IVF, a baseline diagnostic workup should be completed for both partners. This workup identifies the cause of infertility, determines which treatment is appropriate, and designs the IVF protocol if it is the right path.

For the woman:

• AMH (Anti-Müllerian Hormone) — measures ovarian reserve. AMH below 1.0 ng/mL indicates diminished ovarian reserve; below 0.5 ng/mL is considered very low.
• AFC (Antral Follicle Count) — transvaginal ultrasound count of resting follicles. Below 5–7 follicles across both ovaries indicates low reserve.
• FSH and LH (Day 2–3 blood panel) — elevated FSH (above 10–12 IU/L on Day 3) suggests reduced ovarian reserve and reduced response to stimulation.
• TSH (Thyroid Stimulating Hormone) — thyroid dysfunction affects ovulation and implantation. Should be 0.4–2.5 mIU/L for fertility treatment.
• HSG or SSG — imaging that checks whether fallopian tubes are open and the uterine cavity is normal.
• Transvaginal ultrasound — evaluates the uterus for fibroids, polyps, or structural abnormalities; counts antral follicles.

For the male partner:

• Semen analysis — measures count, motility, morphology against WHO 2021 values: concentration ≥16 million/mL, total motility ≥42%, progressive motility ≥30%, normal morphology ≥4% (Kruger strict criteria).
• Sperm DNA Fragmentation Index (DFI) — DFI above 25–30% is associated with reduced fertilisation, impaired embryo development, and increased miscarriage risk.
• Hormone panel (FSH, LH, testosterone) — recommended when semen analysis reveals severe abnormalities, to identify a hormonal cause.

These results together determine whether the couple needs timed intercourse, IUI, IVF, or IVF with ICSI — and they inform the stimulation protocol and medication doses if IVF is indicated.

Which Female Factor Conditions Lead to an IVF Recommendation?

Blocked or Damaged Fallopian Tubes

Bilateral tubal occlusion is an absolute indication for IVF. Fertilisation cannot occur inside a blocked tube; IUI cannot help because sperm cannot reach the egg. IVF bypasses the tubes entirely. Tubal blockage is confirmed by HSG, SSG, or diagnostic laparoscopy.

Endometriosis

Endometriosis affects egg quality, damages fallopian tubes, and creates a hostile environment for implantation. Treatment depends on severity:

• Stage I–II (mild/moderate): Surgical removal of lesions followed by IUI may be appropriate. IVF is not necessarily the first step.
• Stage III–IV (severe/deep infiltrating): Distorted pelvic anatomy, ovarian endometriomas, and poor egg quality make IVF the recommended treatment. The decision to operate on endometriomas versus proceed directly to IVF is individualised — surgery may reduce ovarian reserve further.

PCOS (Polycystic Ovary Syndrome)

PCOS is the most common cause of ovulatory infertility in India. IVF is not the first-line treatment. The recommended sequence:

1. Lifestyle intervention (weight management, exercise, diet) — especially effective when BMI is above 25
2. Ovulation induction with oral agents (letrozole preferred over clomiphene for PCOS per ESHRE 2023)
3. IUI with low-dose gonadotropin stimulation — typically 3–4 cycles
4. IVF — indicated when the above steps fail, or when additional factors (tubal disease, male factor) are present

Diminished Ovarian Reserve (DOR)

Diminished ovarian reserve — AMH below 1.0 ng/mL, AFC below 5–7, or elevated Day 3 FSH — means fewer eggs are available per retrieval cycle. IVF is often indicated earlier because time is the primary resource being conserved. Waiting through multiple IUI cycles when reserve is already low risks further decline. Women with very low reserve (AMH below 0.5 ng/mL) should discuss realistic expectations: typically two to five eggs per retrieval rather than ten to fifteen, with corresponding reduction in viable embryos. Accumulation strategies — banking embryos over multiple retrieval cycles before transfer — are an option some centres offer.

Premature Ovarian Insufficiency (POI)

POI occurs when ovaries stop functioning normally before age 40. Women with POI who have very low or undetectable AMH and consistently elevated FSH may not produce enough eggs for successful own-egg IVF. The most effective treatment path is donor egg IVF — eggs from a young, healthy donor are fertilised and transferred into the woman's prepared uterus. Donor egg IVF success rates (45–55% per transfer) reflect the donor's egg quality, not the recipient's age.

Recurrent Pregnancy Loss with Chromosomal Cause

Couples who have experienced two or more pregnancy losses where genetic testing of pregnancy tissue identified chromosomal abnormalities as the cause are candidates for PGT-A (Preimplantation Genetic Testing for Aneuploidies) within an IVF cycle. PGT-A involves biopsying cells from each Day 5 blastocyst and testing for chromosomal normality before transfer — only euploid embryos are transferred. This requires an IVF cycle; it cannot be done with IUI or natural conception.

Which Male Factor Conditions Lead to an IVF or ICSI Recommendation?

Low Sperm Count and Motility (Oligoasthenospermia)

The key threshold for determining IUI versus IVF is the post-wash Total Motile Sperm Count (TMSC):

Azoospermia (No Sperm in Ejaculate)

Azoospermia affects approximately 1 percent of men and 10–15 percent of infertile men. Treatment depends on type:

• Obstructive azoospermia (blockage, previous vasectomy, congenital absence of vas deferens): Sperm are present in the testes but cannot exit. Retrieved via PESA or TESA and used with ICSI.
• Non-obstructive azoospermia (testicular failure): Micro-TESE can retrieve sperm in approximately 40–60 percent of men. If found, ICSI is performed; if not, donor sperm is the option.

High Sperm DNA Fragmentation

Sperm DNA fragmentation is not captured by standard semen analysis. A DFI above 25–30 percent is associated with reduced fertilisation rates, impaired embryo development, and increased miscarriage risk after successful implantation. ICSI — particularly with advanced selection techniques like IMSI or MACS — can partially address high DFI by selecting the most morphologically intact sperm under extreme magnification. These techniques are not universally available in India and carry additional cost.

What Are the Other Indications for IVF?

Unexplained Infertility

Unexplained infertility accounts for approximately 15–25 percent of infertility cases. The clinical pathway:

1. Timed intercourse with ovulation tracking — 3–6 months
2. IUI with mild stimulation — 3–4 cycles
3. IVF with ICSI — if the above fail after 12 months of trying (under 35), or 6 months (over 35)

The rationale for eventually moving to IVF in unexplained infertility: laboratory fertilisation and embryo culture reveal information about egg quality and fertilisation capacity that cannot be assessed any other way. A couple with “unexplained” infertility may have poor fertilisation in the dish — which immediately clarifies the diagnosis and guides treatment.

Fertility Preservation

• Before cancer treatment: Women diagnosed with cancer should be referred urgently to a fertility specialist before treatment begins. Stimulation, retrieval, and vitrification typically takes 10–14 days and can in many cases be completed between diagnosis and cancer treatment.
• Age-related preservation: Success rates with frozen eggs are highest before age 35. After 37, egg quality decline accelerates.
• Before surgeries that may damage ovarian tissue (e.g., cystectomy for endometrioma).

Genetic Screening (PGT-M)

Couples who carry known single-gene disorders — cystic fibrosis, sickle cell anaemia, thalassemia, Huntington's disease, or BRCA mutations — can use PGT-M (Preimplantation Genetic Testing for Monogenic Disorders) within an IVF cycle to test embryos for the specific mutation before transfer. Only unaffected embryos are transferred. This requires IVF regardless of the couple's fertility status.

When Is IVF Not the Right Recommendation?

• Under 35, trying for less than 12 months, open tubes, normal semen parameters, no diagnosed condition — continue naturally or begin with timed intercourse and ovulation tracking.
• Mild male factor with post-wash TMSC above 5–10 million and open tubes — IUI should be attempted first.
• Ovulatory dysfunction without structural barriers — ovulation induction with letrozole or gonadotropins and IUI is the appropriate first-line treatment.

What Are the Six Steps of an IVF Cycle, Explained Step by Step?

A standard IVF cycle is not a single procedure. It is six coordinated clinical stages, each with a distinct purpose and a specific set of outcomes that determine what happens next.

Understanding each stage — what happens in the clinic, what happens in the lab, and what you experience as a patient — removes the uncertainty that makes IVF feel more overwhelming than it needs to be. The six stages are: consultation and diagnostics, ovarian stimulation, egg retrieval, fertilisation, embryo culture, and embryo transfer.

Step 1 — What Happens During the Consultation and Diagnostic Workup Before IVF Begins?

The pre-cycle workup is the most important phase of IVF — yet patients frequently rush through it or arrive at an IVF cycle with it incomplete. The workup determines your stimulation protocol, your medication doses, and whether any corrective steps are needed before starting. Skipping or abbreviating this phase directly reduces cycle success.

For the woman:

• Complete medical and reproductive history — previous pregnancies, surgeries, known diagnoses, prior fertility treatments
• Hormone blood panel (Day 2 or 3 of your period): FSH, LH, estradiol, AMH, prolactin, TSH, and sometimes total testosterone (particularly for PCOS)
• Transvaginal ultrasound — antral follicle count (AFC) on both ovaries, uterine cavity assessment for fibroids or polyps, ovarian morphology
• HSG or SSG — to confirm tubal patency if not previously established. A blocked tube identified here changes the plan; a hydrosalpinx must be addressed before transfer

For the male partner:

• Semen analysis — count, motility, morphology, volume, and pH assessed against WHO 2021 reference ranges
• Sperm DNA Fragmentation Index (DFI) — particularly when there is a history of recurrent pregnancy loss, repeated IVF failure, or severe morphological abnormality

Protocol Selection

The workup results determine your stimulation protocol. The two most common protocols used in India are:

• GnRH Antagonist Protocol (Short Protocol): Stimulation starts on Day 2–3 of your period. A GnRH antagonist (cetrorelix or ganirelix) is added mid-stimulation to prevent premature ovulation. This is the most widely used protocol globally — preferred for most patients including those with PCOS and low ovarian reserve because it is shorter and carries lower OHSS risk.
• GnRH Agonist Long Protocol: A GnRH agonist (leuprolide acetate) is started in the preceding cycle to suppress the pituitary gland (“down-regulation”) before stimulation begins. Takes approximately four to six weeks total, but offers more controlled stimulation in certain high-responder situations.

Some clinics begin with a combined oral contraceptive pill (OCP) for one to three weeks to synchronise the start of stimulation and manage clinic scheduling. This does not affect cycle outcomes.

Step 2 — How Does Ovarian Stimulation Work and What Should You Expect?

Ovarian stimulation encourages both ovaries to develop multiple follicles simultaneously — rather than the single egg that matures in a natural cycle. The goal is to retrieve eight to fifteen mature eggs per cycle, giving the embryology team enough material to culture multiple embryos and select the best one for transfer.

The Medications Used

Stimulation is achieved with gonadotropins — synthetic versions of FSH and LH. Common branded products used in India include:

• Gonal-F (follitropin alfa) and Puregon (follitropin beta) — recombinant FSH
• Menopur (menotropin) — contains both FSH and LH, derived from purified urinary hormones
• Fostimon (urofollitropin) — highly purified urinary FSH

Injections are subcutaneous (under the skin, into the abdomen) using very fine needles — similar to insulin injections. Most patients self-administer after a brief demonstration at the clinic.

What Happens During the 10–14 Days of Stimulation

• Days 1–5: Low to moderate doses of gonadotropins are administered daily. The ovaries begin developing multiple follicles.
• Days 5–8: Monitoring begins — clinic visits every 2–3 days for transvaginal ultrasound and blood estradiol. Doses are adjusted based on your response.
• Days 8–12: When leading follicles approach 14mm, a GnRH antagonist (Cetrotide or Orgalutran) is added to prevent premature ovulation.
• Trigger shot: When three or more follicles reach 17–20mm, the trigger injection is administered. Retrieval is scheduled exactly 34–36 hours later.
  • hCG trigger (Ovitrelle): Standard trigger for most patients.
  • GnRH agonist trigger (triptorelin or leuprolide): Used for high-OHSS-risk patients (PCOS, estradiol above 3,000–4,000 pg/mL). Significantly reduces OHSS risk — a freeze-all cycle is planned from the start in these cases.

Step 3 — What Happens During Egg Retrieval and What Should You Expect?

Egg retrieval — clinically called transvaginal oocyte aspiration or OPU (Ovum Pick-Up) — is the only surgical step in an IVF cycle. It is completed in 15 to 20 minutes under intravenous sedation, so you feel nothing.

The Procedure

You arrive fasting (no food or water from midnight). An IV line is placed for sedation. With you in a lithotomy position, the reproductive endocrinologist inserts a transvaginal ultrasound probe fitted with a needle guide. A fine aspiration needle passes through the vaginal wall directly into each follicle visible on ultrasound, suctioning the fluid and egg into a collection tube. The embryologist examines each tube under a microscope immediately to identify and classify each egg:

• Mature (MII): Fully developed, ready for fertilisation — this is what you want.
• Immature (MI or GV): Not yet ready for ICSI; can sometimes be matured in the lab (IVM) but this is not standard.
• Degenerate: Not viable.

What the Numbers Mean

Eight to fifteen mature eggs is generally considered a good response for women with normal ovarian reserve. Fewer than three to four eggs significantly reduces the probability of reaching a high-quality blastocyst — not because fewer eggs means lower quality, but because natural attrition at each stage means a proportion will not progress. Women with low ovarian reserve may routinely retrieve two to five eggs. A cycle that retrieves two eggs and produces one good blastocyst is a clinically useful outcome — one quality embryo is all that is needed for transfer.

Post-Retrieval

You rest at the clinic for one to two hours. A responsible adult must take you home — you cannot drive. Mild bloating, pelvic cramping, and light spotting are normal for one to two days. Paracetamol is recommended for pain; avoid ibuprofen (NSAIDs can affect implantation). Most women return to light work the following day. The male partner provides a semen sample on the same day as retrieval; if the male partner has azoospermia, a previously frozen surgical retrieval sample is used.

Step 4 — What Is the Difference Between Standard IVF and ICSI Fertilisation in the Lab?

Standard IVF (Conventional Insemination)

The prepared sperm sample is added to each dish containing a mature egg — approximately 50,000 to 100,000 motile sperm per egg — and left to fertilise naturally over four to six hours. At 16 to 18 hours after insemination, the embryologist checks for two pronuclei (2PN) — one from the egg and one from the sperm. A 2PN embryo is normally fertilised. Embryos with 1PN or 3PN are abnormally fertilised and are not used.

ICSI (Intracytoplasmic Sperm Injection)

The embryologist identifies individual sperm under 200–400x magnification. A single sperm is immobilised and drawn into a glass microneedle thinner than a human hair. Each mature egg is held in place with a holding pipette, and the microneedle deposits the single sperm directly inside the egg. Fertilisation is checked at the same 16–18 hour timepoint.

Fertilisation Rates to Expect

A fertilisation report is communicated to you on Day 1 — the morning after retrieval. If you had eight mature eggs retrieved and six fertilised, you have six 2PN embryos to culture.

Step 5 — What Happens During Embryo Culture Between Day 1 and Day 5?

After fertilisation, embryos are placed in specialised incubators in carefully controlled culture media — nutrient solutions that replicate the environment of the fallopian tube and uterus. The embryology team monitors development daily without disturbing the embryos unnecessarily.

Embryo Development Milestones

Blastocyst Grading (Gardner Scale)

Blastocysts are graded on the Gardner scale: expansion stage (1–6), inner cell mass grade (A, B, or C), and trophectoderm grade (A, B, or C). A 4AA blastocyst (fully expanded, excellent ICM, excellent trophectoderm) is the highest grade. A 3BB is a good-quality blastocyst with solid implantation potential. Grade B embryos are routinely transferred with excellent success rates — A versus B grading is not the difference between success and failure.

Why Day 5 Transfer Is Preferred Over Day 3

• Day 3 cleavage-stage transfer: Implantation rate approximately 30–35% per embryo transferred
• Day 5 blastocyst transfer: Implantation rate approximately 50–60% per embryo transferred

The trade-off is attrition: not all embryos reach blastocyst. If you have three Day 3 embryos and culture to Day 5, you may have one or two blastocysts — or none. Some clinics recommend Day 3 transfer when the number of embryos is very low (one or two), to avoid the risk of having nothing to transfer. This is a clinical judgment made by the embryologist based on embryo quality and number.

Typical Attrition from Retrieval to Blastocyst

From ten mature eggs, a realistic expectation is five to six fertilised embryos, four to five reaching Day 3, and two to three blastocysts. This is biological selection — it happens naturally in the body too, just invisibly.

Step 6 — What Happens During Embryo Transfer and What Is a Freeze-All Cycle?

Embryo transfer is the final procedural step of an IVF cycle. No sedation, no needles — most patients describe it as comparable to a cervical smear (Pap test).

The Procedure

You arrive with a comfortably full bladder (it straightens the angle between the cervix and uterus, making catheter passage easier, and provides a clear window for abdominal ultrasound guidance). The doctor passes a soft, flexible catheter through the cervix into the uterine cavity. The embryologist loads the selected embryo into the catheter tip, and the doctor gently deposits it at the optimal position in the uterine cavity — typically one to two centimetres from the fundus — under real-time ultrasound visualisation. The procedure takes five to ten minutes.

You rest at the clinic for twenty to thirty minutes and then go home. There are no restrictions on activity beyond common sense — avoid strenuous exercise, heavy lifting, and hot baths for a few days. There is no clinical evidence that bed rest after embryo transfer improves implantation rates.

Single Embryo Transfer (SET) as the Standard

Transferring one embryo at a time is the standard of care at most accredited Indian IVF centres. Transferring two embryos increases the probability of at least one implanting, but dramatically increases the risk of twin pregnancy — which carries significantly higher risks of preterm birth, low birth weight, gestational diabetes, and maternal complications. The cumulative live birth rate from two single embryo transfers (fresh then frozen) is equivalent to or better than one double embryo transfer, with far lower complication rates.

Post-Transfer Progesterone Support

After transfer, you take progesterone supplementation to support the endometrium during the implantation window. Administered as vaginal pessaries (Cyclogest, Utrogestan), vaginal gel (Crinone 8%), intramuscular injections (progesterone in oil), or oral micronised progesterone. All routes are clinically comparable in outcomes. Progesterone is continued until the pregnancy blood test and, if positive, typically until 10–12 weeks when the placenta takes over production.

The Two-Week Wait (TWW)

The period between embryo transfer and the beta-hCG blood test (typically 10 to 14 days) is the most emotionally demanding phase of an IVF cycle. Implantation, if it occurs, happens between 6 and 10 days after transfer. Progesterone supplementation itself causes symptoms — bloating, breast tenderness, mild cramping — identical to early pregnancy symptoms, making self-assessment meaningless. Home pregnancy tests before Day 10 post-transfer can produce false positives (residual trigger hCG) or false negatives. The serum beta-hCG blood test at your clinic is the only reliable measure.

What Is a Freeze-All Cycle and When Is It Recommended?

A freeze-all cycle is an IVF cycle in which all viable blastocysts are frozen immediately after reaching Day 5, and no fresh embryo transfer takes place. Transfer is deferred to a subsequent Frozen Embryo Transfer (FET) cycle — typically one to two months later.

Freeze-all is recommended when:

• OHSS risk is elevated — PCOS or high responders with estradiol above 3,000–4,000 pg/mL or more than 20 follicles. A GnRH agonist trigger is used and fresh transfer avoided.
• Endometrial lining is suboptimal on retrieval day — thin endometrium (below 7mm) or irregular pattern lowers implantation probability. Deferring to FET allows proper preparation.
• Premature progesterone elevation — an unfavourable estrogen/progesterone ratio before retrieval impairs endometrial receptivity.
• PGT-A or PGT-M testing is required — embryos are biopsied and sent for genetic analysis; results take one to two weeks. Fresh transfer in the same cycle is not possible.
• Patient is unwell — fever, illness, or any condition making transfer inadvisable in the current cycle.

Complete IVF Timeline Overview

What Does IVF Actually Cost in India — Including Medications, Add-Ons, and Multiple Cycles?

The price most Indian IVF clinics advertise is the base procedure cost. It is almost never the number you will pay at the end of a cycle. Medications, add-on techniques, cryopreservation, and FET cycles each carry separate price tags that can double the quoted figure. This section breaks down every cost category so you can build a realistic budget before you begin.

What Is Included vs. Excluded in a Typical IVF “Package” Quote?

How Much Do IVF Medications Cost in India?

Stimulation medications are the single largest hidden cost — and the most variable, because dose depends on ovarian reserve and response.

What Add-On Costs Can Inflate the Final Bill?

What Does a Frozen Embryo Transfer (FET) Cycle Cost?

A FET cycle costs roughly 20–40% of a full fresh IVF cycle. Couples with frozen blastocysts have additional transfer opportunities at substantially lower cost than a repeat full stimulation cycle.

IVF Cost by City in India

How Does IVF Cost in India Compare to Other Countries?

Is IVF Covered by Health Insurance in India?

For most patients, IVF is an out-of-pocket expense. Standard health insurance plans do not cover IVF. A small and growing number of insurers have introduced fertility riders: ICICI Lombard iHealth, Niva Bupa ReAssure, Bajaj Allianz Health Guard Gold. Common terms: 24–48 month waiting period; sub-limit of ₹50,000–₹1,50,000; medications typically excluded. Employer group plans at multinationals and tech companies increasingly include IVF coverage — check your HR policy document explicitly. Pre-cycle diagnostic tests (AMH, semen analysis, HSG) may be covered under standard plans as diagnostics.

What Are the Real IVF Success Rates in India — and What Does “Success” Actually Mean?

IVF success rates are the most cited and most misunderstood numbers in fertility medicine. The metric being reported determines the number — and clinics often report the most flattering metric without clarifying which one it is.

Which “Success Rate” Metric Should You Ask For?

IVF Live Birth Rate by Age in India

Sources: ESHRE European ART Data (2022), ICMR National ART Registry (2023–24), published outcomes from major Indian IVF programmes. These are population averages — individual results vary based on diagnosis, ovarian reserve, embryo quality, and clinic.

Cumulative IVF Success Rates Over Multiple Cycles

Why Do Success Rates Decline With Age — What Is Happening Biologically?

The age-related decline in IVF success is almost entirely driven by egg quality — specifically, the rate of chromosomal abnormalities (aneuploidies) in eggs. This is critical: the uterus retains its receptivity well into the mid-40s. When a 45-year-old receives a donor embryo made from a 28-year-old's egg, her uterus achieves implantation rates comparable to a 28-year-old. The biological clock runs in the ovary, not the uterus.

What Factors Beyond Age Affect IVF Success?

• Ovarian reserve (AMH & AFC): Predicts eggs retrieved per cycle — not quality. AMH below 0.5 ng/mL = 1–4 eggs typically; 1.5–3.0 ng/mL = 8–15 eggs
• Embryo quality (blastocyst grade): Grade AA vs. BB blastocysts — real but not dramatic difference; Grade CC has substantially lower implantation potential
• Endometrial thickness: Optimal 8–12mm at transfer; below 7mm is associated with lower implantation rates
• Sperm DNA fragmentation: DFI above 25–30% — lower fertilisation, higher embryo arrest rate, higher miscarriage risk
• BMI: Optimal 19–25. Obesity (BMI >30) reduces live birth rate by 15–25% per cycle
• Smoking: Active smoking reduces IVF success by 30–50%. Quit at least 3 months before starting — oocytes take 3 months to complete development
• Prior live birth: “Proven fertility” is consistently associated with higher subsequent IVF success

How Should You Evaluate a Clinic's Claimed Success Rate?

• Ask: “Is this a live birth rate or clinical pregnancy rate?” — the answer should be live birth rate
• Ask: “Is this per embryo transfer or per cycle started?” — per cycle started is more honest
• Ask: “Is this age-stratified?” — a single figure covering all ages is meaningless for your decision
• Ask: “Is this data submitted to the ICMR ART Registry?” — registry submission = accountability
• Treat any unqualified success rate above 60–65% with significant scepticism — biologically implausible as a population average across all ages

What Are the Real Risks and Side Effects of IVF?

IVF is safe for the vast majority of patients when performed in accredited facilities. But safe does not mean risk-free. Understanding what can go wrong — and at what probability — helps you recognise symptoms early, ask the right questions, and protect your own wellbeing.

Ovarian Hyperstimulation Syndrome (OHSS) — The Most Significant IVF Risk

OHSS occurs when ovaries over-respond to stimulation medications, becoming enlarged and leaking fluid into the abdominal and chest cavities. It exists on a spectrum from mild and self-limiting to severe and requiring hospitalisation. Severe OHSS occurs in approximately 0.5–2% of IVF cycles.

Prevention in high-risk patients (PCOS, AMH >4 ng/mL, >18 follicles): GnRH antagonist protocol, lower stimulation doses, GnRH agonist trigger instead of hCG, and freeze-all strategy (no fresh transfer eliminates late-onset OHSS). Ask your clinic specifically: “What is your OHSS prevention protocol for my ovarian reserve profile?”

Egg Retrieval Risks

• Bleeding: Significant internal bleeding occurs in ~0.05–0.1% of retrievals; usually resolves without intervention
• Pelvic infection: ~0.3–0.6% of cycles; prophylactic antibiotics (doxycycline) are standard. Risk is higher with history of pelvic infections
• Ovarian torsion: Stimulated enlarged ovaries are heavier and more mobile — torsion risk highest during stimulation and days post-retrieval. Sudden severe unilateral abdominal pain with nausea = surgical emergency; seek immediate assessment
• Adjacent organ injury: Bowel, bladder, blood vessel injury — extremely rare (<0.01%) with experienced ultrasound-guided technique

Multiple Pregnancy Risk

Multiple pregnancy is a consequence of transferring more than one embryo — not a complication of IVF itself. Twin IVF pregnancies carry significantly elevated risk: preterm birth in ~60% of cases (vs. 8–10% singleton), low birth weight, gestational diabetes, pre-eclampsia, Twin-to-Twin Transfusion Syndrome (TTTS) in monochorionic twins. Single Embryo Transfer (SET) is the standard of care at evidence-based centres — equivalent cumulative live birth rate to double transfer over sequential cycles, with a fraction of the obstetric complications.

Other Medical Risks

Medication Side Effects During an IVF Cycle

• Gonadotropins (stimulation phase): Injection site reactions, abdominal bloating (worsens toward end of stimulation), mood fluctuations, breast tenderness, fatigue
• GnRH antagonist: Generally well-tolerated; mild headache, injection site reactions
• Progesterone support (post-transfer): Vaginal pessaries cause local discharge; intramuscular injections cause injection-site hardness and pain accumulating over days. Systemic progesterone effects: bloating, breast tenderness, mood changes, fatigue — all overlap with early pregnancy symptoms, making symptom-reading during the two-week wait unreliable

The Psychological and Emotional Impact of IVF

ESHRE clinical guidelines recognise infertility treatment as a major life stressor warranting dedicated psychosocial support. The specific emotional challenges at each phase: anticipatory anxiety during stimulation monitoring, the Day 1 fertilisation report (fewer embryos than expected is experienced as a loss), Day 5 attrition (not all fertilised eggs reach blastocyst), the two-week wait (universally described as the most difficult phase), and a negative pregnancy test — which clinical literature equates to a grief response comparable to bereavement in many patients.

In the Indian context, family pressure, social stigma, and the cultural expectation of privacy prevent many patients from accessing support from existing networks. Professional counselling — ask whether your clinic has a dedicated counsellor — and peer support communities provide a qualitatively different kind of support to the isolation that many couples describe.

How Do You Choose the Right IVF Clinic in India?

Over 2,500 registered ART clinics operate across India. The factors patients most commonly use to choose — price, location, and a clinic's own marketing claims — are among the least predictive of actual outcome. The factors that most directly determine your result are: laboratory quality, the clinical experience of the reproductive endocrinologist who personally manages your case, evidence-based protocols, and transparent reporting.

Accreditation and Registration — What Is the Baseline vs. a Quality Signal?

• ART (Regulation) Act, 2021 registration: Legal minimum — required for all clinics. Request to see the certificate; a legitimate clinic produces it without hesitation
• NABH accreditation: National Accreditation Board for Hospitals — facility-level quality and safety audit. A positive signal. Not all good clinics are NABH-accredited
• NABL accreditation: National Accreditation Board for Testing and Calibration Laboratories — applies to the IVF laboratory specifically. Relatively rare; its presence is a strong lab quality signal
• ISO 9001 / JCI: Applies to operational management systems, not clinical outcomes specifically

Why Does Annual IVF Volume Matter?

Volume matters for two reasons: statistical reliability of success rate data, and maintenance of embryological skill. A clinic performing 50 IVF cycles per year and reporting 55% success is reporting 50 cases — too small a sample for statistical stability; year-to-year fluctuation of 10–15 points is noise, not signal. A clinic performing 300–500+ cycles/year produces statistically meaningful data. Ask: “How many IVF cycles do you perform per year?” and “How many full-time embryologists work in your lab?” A high-quality IVF lab maintains approximately one experienced embryologist per 150–200 cycles/year.

How to Assess Laboratory Quality

• Air quality: High-quality IVF labs use HEPA and activated carbon filtration in a positive-pressure clean room (ISO Class 5 or better). VOCs from building materials damage embryos. Ask: “What air filtration does your lab use?”
• Incubators: Benchtop incubators (Cook K-System, Vitrolife Geri, Esco Miri) maintain individual microenvironments per dish — less temperature disruption than large box incubators. Time-lapse (EmbryoScope, Miri TL) enables continuous monitoring without removing embryos
• Culture media: Established brands — Vitrolife, Cook Medical (K-MINC), Origio — indicate commitment to embryo quality
• Blastocyst development rate: Above 50–55% of fertilised eggs reaching Day 5 blastocyst = good laboratory culture conditions. Ask for this number
• Vitrification survival rate: Above 90% blastocyst survival after thaw = competent cryopreservation technique

Red Flags When Evaluating an IVF Clinic

• Recommending IVF at the first consultation before completing diagnostics for both partners
• Quoting a success rate without specifying age group, denominator (per transfer vs. per cycle started), or outcome metric (pregnancy rate vs. live birth rate)
• Guaranteed IVF success or money-back programmes — financial products with undisclosed eligibility criteria
• Routine double embryo transfer without specific clinical justification for your case
• Recommending ERA, time-lapse, IMSI, and endometrial scratch routinely for all patients regardless of history — each add-on needs a specific clinical reason
• Creating artificial urgency to start immediately before your diagnostic workup is complete
• Discouraging second opinions — a high-quality specialist welcomes them

Chain Clinic vs. Independent Fertility Centre — How to Decide

12 Questions to Ask at Your First IVF Clinic Consultation

IVF vs IUI — Full Comparison and Decision Guide

IUI is simpler, less invasive, and costs a fraction of IVF per cycle. IVF has a significantly higher per-cycle success rate. The decision between them is not a choice between expensive and cheap — it is a clinical determination based on your diagnosis, age, and how efficiently your treatment path uses time.

When Is IUI the Appropriate First Step?

IUI is appropriate when all of the following are true:

• ✅ At least one fallopian tube is confirmed open (HSG or saline sonogram verified)
• ✅ Post-wash TMSC ≥5–10 million
• ✅ Ovulation is present or can be induced (letrozole, clomiphene, or low-dose gonadotropins)
• ✅ Age is under 37 and ovarian reserve is adequate (AMH ≥0.5–1.0 ng/mL)
• ✅ No diagnosis that makes IUI structurally ineffective

When Should You Skip IUI and Go Directly to IVF?

How Many IUI Cycles Should You Try Before Moving to IVF?

Frequently Asked Questions About IVF in India

Fifteen specific, evidence-based answers to the questions patients most commonly arrive at a clinic without having answered — including questions that clinics often do not proactively address.

Find IVF Clinics Near You

FertilityNetwork lists verified fertility clinics across India with information on treatments offered, specialist experience, location, and contact details.

Related Guides